Latest filing published 13 Feb 2017 for Adverum Biotechnologies, Inc..
Insider track record
No signal scores available.
Amber Salzman: trading record in brief
All filings by Amber Salzman on record concern Adverum Biotechnologies, Inc. In total, 2 filings cover trades dated from 11 May 2016 to 9 February 2017.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 13 February 2017, reports a share grant in Adverum Biotechnologies, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Amber Salzman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 262,000 shares0Common StockSEC:0001209191-17-010126:0
- 629,766 shares0Common StockSEC:0001209191-16-120043:0
2 of 2 declarations